Zacks Investment ResearchWed, 03 Jun 2026 14:36:07 GMTAbivax SA Sponsored ADR (ABVX) Loses 41.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerABVX-1.79%
Seeking AlphaTue, 02 Jun 2026 13:51:51 GMTABIVAX Société Anonyme (ABVX) Discusses Positive Phase III ABTECT Trial Results for Obefazimod in Ulcerative Colitis TranscriptABVX-1.79%
WSJTue, 02 Jun 2026 08:45:00 GMTAbivax Shares Plunge After Company Reports Adverse Events in Key Drug TrialABVX-1.79%
InvezzTue, 02 Jun 2026 08:21:37 GMTAbivax stock crashes as safety fears overshadow bowel disease drug trial winABVX-1.79%
CNBCTue, 02 Jun 2026 07:20:30 GMTBiotech takeover target Abivax sinks over 30% after bowel disease drug trial updateABVX-1.79%
Investors Business DailyMon, 01 Jun 2026 22:29:31 GMTAbivax Hits 'Best-Case' Scenario For Ulcerative Colitis Drug; So, Why Did Shares Plummet?ABVX-1.79%
Zacks Investment ResearchThu, 28 May 2026 17:01:13 GMTWhat Makes Abivax SA Sponsored ADR (ABVX) a Strong Momentum Stock: Buy Now?ABVX-1.79%
The Motley FoolTue, 07 Apr 2026 19:00:00 GMTThis Beaten-Down Drug Stock Is Down Over 10% -- Is It Finally a Buy?ABVX-1.79%
Seeking AlphaWed, 01 Apr 2026 15:00:30 GMTAbivax: Obefazimod's Strategic Scarcity Drives Optionality (Maintaining Buy)ABVX-1.79%
BenzingaTue, 24 Mar 2026 17:53:26 GMTAbivax CEO Downplays Sale Talk, Eyes Capital Raise As Key Trial Data Readout NearsABVX-1.79%
CNBCTue, 24 Mar 2026 15:42:25 GMTAbivax in no rush for a deal, confident key June trial data can secure better terms for partnerships, CEO tells CNBCABVX-1.79%
The Motley FoolFri, 20 Mar 2026 09:34:00 GMT2 Healthcare Stocks to Buy Before They Get Bought OutABVX-1.79%
